Kober-Hasslacher et al., 2019 - Google Patents
The unsolved puzzle of c-Rel in B cell lymphomaKober-Hasslacher et al., 2019
View HTML- Document ID
- 10303890113952896220
- Author
- Kober-Hasslacher M
- Schmidt-Supprian M
- Publication year
- Publication venue
- Cancers
External Links
Snippet
Aberrant constitutive activation of Rel/NF-κB transcription factors is a hallmark of numerous cancers. Of the five Rel family members, c-Rel has the strongest direct links to tumorigenesis. c-Rel is the only member that can malignantly transform lymphoid cells in …
- 108010001859 Proto-Oncogene Proteins c-rel 0 title abstract description 268
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cardona-Benavides et al. | Genetic abnormalities in multiple myeloma: prognostic and therapeutic implications | |
| Lasorsa et al. | Immune checkpoint inhibitors in renal cell carcinoma: molecular basis and rationale for their use in clinical practice | |
| Beato et al. | Peptidyl arginine deiminase 2 (PADI2)-mediated arginine citrullination modulates transcription in cancer | |
| Wöss et al. | TYK2: an upstream kinase of STATs in cancer | |
| García-Díaz et al. | Mycosis fungoides and sézary syndrome: An integrative review of the pathophysiology, molecular drivers, and targeted therapy | |
| Shiraz et al. | The current genomic and molecular landscape of Philadelphia-like acute lymphoblastic leukemia | |
| Visco et al. | Oncogenic mutations of MYD88 and CD79B in diffuse large B-cell lymphoma and implications for clinical practice | |
| Giunta et al. | Epigenetic regulation in melanoma: facts and hopes | |
| Miwa et al. | Therapeutic targets and emerging treatments in advanced chondrosarcoma | |
| Mulet-Margalef et al. | Challenges and therapeutic opportunities in the dMMR/MSI-H colorectal cancer landscape | |
| Kober-Hasslacher et al. | The unsolved puzzle of c-Rel in B cell lymphoma | |
| Kaminska et al. | Single-cell omics in dissecting immune microenvironment of malignant gliomas—challenges and perspectives | |
| Kennedy et al. | Aberrant activation of NF-κB signalling in aggressive lymphoid malignancies | |
| Longo et al. | What are the biomarkers for immunotherapy in SCLC? | |
| Berendsen et al. | Molecular genetics of relapsed diffuse large B-cell lymphoma: insight into mechanisms of therapy resistance | |
| Rodríguez-Sevilla et al. | Recent advances in the genetic of MALT lymphomas | |
| Di Battista et al. | Genetics and pathogenetic role of inflammasomes in Philadelphia negative chronic myeloproliferative neoplasms: a narrative review | |
| Feoktistova et al. | A20 promotes ripoptosome formation and TNF-induced apoptosis via cIAPs regulation and NIK stabilization in keratinocytes | |
| Bröckelmann et al. | Targeting DNA repair, cell cycle, and tumor microenvironment in B cell lymphoma | |
| Schavgoulidze et al. | Multiple myeloma: heterogeneous in every way | |
| Aung et al. | PD1/PD-L1 expression in blastic plasmacytoid dendritic cell neoplasm | |
| Simeon et al. | Molecular classification and pharmacogenetics of primary plasma cell leukemia: an initial approach toward precision medicine | |
| Wong et al. | IRF4 as an oncogenic master transcription factor | |
| de Jonge et al. | Impact of MYC on anti-tumor immune responses in aggressive B cell non-hodgkin lymphomas: consequences for cancer immunotherapy | |
| Xing et al. | Polymerase epsilon-associated ultramutagenesis in cancer |